Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn’s Disease is a research paper published in Inflammatory Bowel Diseases (2021). On theSindex it has a DataRank of 0. It has been cited 34 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: T32DK007742
National Institutes of Health
FWCI
2.73
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals